Financial Data and Key Metrics Changes - The meeting confirmed that a majority of the voting power of Teladoc Health's outstanding capital stock was present, indicating strong shareholder engagement [4][11] - Proposals regarding the election of directors and executive compensation were approved, reflecting shareholder confidence in management [11] Business Line Data and Key Metrics Changes - Specific financial data and performance metrics for individual business lines were not disclosed during the meeting [10] Market Data and Key Metrics Changes - No specific market data or key metrics were discussed in the meeting [10] Company Strategy and Development Direction and Industry Competition - The meeting focused on the election of directors and approval of executive compensation, suggesting a stable governance structure [11] - The approval of the incentive award plan indicates a commitment to aligning executive performance with shareholder interests [8] Management's Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during the meeting [10] Other Important Information - The meeting was conducted virtually, allowing stockholders to participate and vote online [5][9] - The results of the votes will be reported in a Form 8-K within four business days, ensuring transparency [11] Q&A Session Summary - No questions were raised during the Q&A session, indicating either satisfaction with the proposals or a lack of immediate concerns from shareholders [10]

Core Viewpoint - JPMorgan analyst Lisa C. Gill maintains a Neutral rating on Teladoc Health, Inc with a reduced price target of $9, down from $11 [1] Financial Performance - Teladoc reported first-quarter revenue of $629.4 million, a decrease of 3%, but exceeded the consensus estimate of $619.29 million [1] - The company incurred a first-quarter loss of 53 cents per share, which was worse than the analyst estimate of a loss of 34 cents per share [1] Future Revenue Guidance - For the second quarter, Teladoc expects revenue between $614 million and $633 million, and for the full year, revenue is projected to be between $2.47 billion and $2.58 billion [2] - Analysts are forecasting full-year revenue of $2.52 billion [2] Earnings Outlook - Teladoc has lowered its full-year earnings outlook, now anticipating a 2025 loss of $0.90 to $1.40 per share, down from a previous guidance of a loss of $0.50 to $1.10 per share [3] - Analysts forecast a loss of 93 cents per share for 2025 [3] Revenue and EBITDA Estimates - Following the first-quarter earnings, Gill adjusted her fiscal 2025 revenue estimate to $2.516 billion from $2.520 billion, and her adjusted EBITDA estimate to $282 million, down from $294 million [3] - For fiscal 2026, Gill lowered her revenue estimate to $2.547 billion from $2.560 billion and adjusted EBITDA estimate to $304 million from $314 million [4] Valuation and Market Position - Gill established a December 2025 price target of $9 based on an EV/adjusted EBITDA multiple of approximately 6.5 times her 2026 adjusted EBITDA estimate, which is a significant discount to Teladoc's pre-pandemic historical average multiple [4] - The company faces challenges and uncertainties in the DTC behavioral health business and a volatile macroeconomic environment [5] Growth Potential - Despite current challenges, there is a sizable Total Addressable Market (TAM) with significant growth potential due to continued virtual care adoption, a leading competitive position, and expansion opportunities [6] - The company has an attractive margin profile and a strong balance sheet, being EBITDA and cash flow positive [6] Stock Performance - Teladoc shares were up 2.4% at $7.43 as of the last check on Friday [6]

Group 1: Investment Opportunities - Equity markets present bargains with stocks that have underperformed but may rebound as conditions improve [1] - Moderna is highlighted as a beaten-down stock with promising prospects due to its advancements in mRNA technology and a strong pipeline of potential products [2][4] - Moderna's revenue guidance is projected at $2 billion, primarily from its COVID vaccine efforts, and the company plans to cut operating expenses by $1.4 billion to $1.7 billion by 2027 [8][9] Group 2: Company-Specific Analysis - Moderna - Moderna's mRNA-4157, a personalized cancer vaccine, has shown strong results in phase 2 studies and is currently in phase 3 trials [6] - The company is also developing a standalone influenza vaccine and a combined COVID/flu shot, both nearing approval [7] - Despite a decline in stock performance over the past three years, Moderna's potential for growth remains strong due to its innovative pipeline and cost-cutting measures [9] Group 3: Investment Risks - Teladoc Health, a telemedicine company, has seen a slowdown in revenue growth and remains unprofitable despite high gross margins [10] - In the first quarter, Teladoc's revenue decreased by 3% year over year to $629.4 million, with a net loss per share of $0.53 [11] - The company faces significant challenges, including a competitive landscape and declining membership in its therapy service, BetterHelp [13][14]

Core Viewpoint - Teladoc Health Inc. reported better-than-expected first-quarter 2025 results, but the outlook for 2025 has disappointed investors, leading to a 4.6% decline in shares since the earnings report [1] Financial Performance - The company incurred an adjusted loss of 19 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 33 cents and improved from a loss of 49 cents in the same quarter last year [2] - Operating revenues were $629.4 million, down from $646.1 million year-over-year, but exceeded the consensus estimate by 1.9% [2] - Access fees revenue decreased by 6% year-over-year to $525.7 million, missing the consensus estimate by 1.5% [3] - Other revenues increased by 16% year-over-year to $103.6 million, beating the consensus estimate by 22.9% [3] Segment Performance - The Integrated Care segment generated revenues of $389.5 million, a 3% year-over-year increase, surpassing both the Zacks Consensus Estimate and internal estimates [6] - The BetterHelp segment's revenues declined by 11% year-over-year to $239.9 million, although it beat the consensus estimate [7] Operational Metrics - Total visits decreased by 3% year-over-year to 4.4 million, falling short of the consensus estimate by 0.1% [8] - U.S. Integrated Care Members reached 102.5 million, a 12% year-over-year increase, exceeding the consensus mark by 1.2% [8] Expense and Cash Flow - Total expenses rose by 2.3% year-over-year to $750 million, exceeding internal estimates [5] - Operating cash flow improved to $15.9 million from $8.9 million year-over-year, while free cash outflow decreased to $15.7 million from $26.6 million [10] Outlook - For the second quarter, Integrated Care segment revenues are expected to grow by 0.25%-2.75% year-over-year, with an adjusted EBITDA margin forecasted between 13.25-14.75% [11] - Full-year revenues are projected to be between $2.468 billion and $2.576 billion, with a net loss expected between 90 cents and $1.40 per share [15]

Group 1 - The article suggests that investors should consider positioning themselves in undervalued stocks that are mispriced by the market as May approaches [1] - There is an emphasis on the importance of conducting personal research or consulting a financial advisor before making investment decisions [3] - The article does not provide specific stock recommendations or advice on suitability for particular investors [4] Group 2 - The content is intended for informational purposes only and does not constitute a solicitation to buy or sell securities [3] - The article clarifies that past performance is not indicative of future results, highlighting the inherent risks in investing [4] - The authors of the article are identified as third-party contributors, which may include both professional and individual investors [4]

Membership and Enrollment - U.S. Integrated Care members increased by 10.7 million, or 12%, to 102.5 million at March 31, 2025, compared to the same period in 2024[108]. - Chronic care program enrollment increased by 3% to 1.151 million at March 31, 2025, compared to 1.121 million at March 31, 2024[109]. Revenue and Financial Performance - Total revenue for the three months ended March 31, 2025, was $629.4 million, a decrease of $16.8 million, or 3%, compared to $646.1 million in the same period of 2024[125]. - Integrated Care segment revenue increased by $12.4 million, or 3%, to $389.5 million for the three months ended March 31, 2025, driven by higher chronic care program enrollment and telemedicine product revenue[143]. - BetterHelp total revenues decreased by $29.1 million, or 11%, to $239.9 million for the three months ended March 31, 2025, driven by a 4% decrease in average monthly paying users[148]. Profitability and Loss - Net loss for the three months ended March 31, 2025, was $93.0 million, an increase of $11.1 million, or 14%, compared to a net loss of $81.9 million in the same period of 2024[124]. - Adjusted EBITDA for the three months ended March 31, 2025, was $58.1 million, a decrease of $5.0 million, or 8%, compared to $63.1 million in the same period of 2024[125]. - Adjusted EBITDA decreased by $7.8 million, or 50%, to $7.7 million, with an adjusted EBITDA margin of 3.2%[148]. Expenses - Advertising and marketing expenses decreased by $15.1 million, or 8%, to $168.2 million for the three months ended March 31, 2025, primarily due to lower digital and media advertising costs[128]. - Technology and development expenses decreased by $11.4 million, or 14%, to $70.0 million for the three months ended March 31, 2025, reflecting lower employee compensation costs[129]. - Cost of revenue increased by $2.3 million, or 1%, to $196.8 million for the three months ended March 31, 2025, primarily driven by higher labor and technology costs[126]. - Cost of revenue, exclusive of depreciation, amortization, and stock-based compensation, decreased by $7.6 million, or 10%, to $65.2 million, primarily due to lower therapist costs[148]. Cash Flow and Capital Expenditures - Net cash provided by operating activities was $15.9 million for the three months ended March 31, 2025, compared to $8.9 million for the same period in 2024[157]. - Cash used in investing activities was $123.3 million, including $64.6 million for the acquisition of Catapult Health and $27.0 million for acquiring securities of a private company[159]. - Free cash flow was an outflow of $15.7 million for the three months ended March 31, 2025, compared to an outflow of $26.6 million for the same period in 2024[161]. - As of March 31, 2025, cash and cash equivalents totaled $1,193.3 million, with expectations of continuing positive operating cash flows for 2025[151]. Impairments and Restructuring - Goodwill impairment of $59.1 million was recognized in the three months ended March 31, 2025, related to the acquisition of Catapult Health[132]. - Restructuring costs decreased to $4.3 million for the three months ended March 31, 2025, from $9.7 million in the same period of 2024, reflecting a reduction in employee transition and severance costs[134][135]. Market and Competitive Environment - The company faces risks related to competition, particularly from health plans that may develop solutions replicating its services[108]. - The company expects tariffs on imported goods to impact consolidated results of operations due to retaliatory tariffs from affected countries[107]. - The company’s business is subject to seasonality, with the highest level of visit and fee revenue typically occurring in the first and fourth quarters[112]. Financial Metrics and Estimates - Adjusted EBITDA is used as a key measure of performance, consisting of net loss before provision for income taxes and other specified expenses[117]. - Free cash flow is defined as net cash provided by operating activities less capital expenditures and capitalized software development costs[118]. - The company evaluates its estimates and judgments related to revenue recognition and other financial metrics on an ongoing basis[115]. - Revenue from the five largest customers accounted for 31% of total Integrated Care segment revenue for the three months ended March 31, 2025[166]. - A 1% change in interest rates would result in a change of interest income generated from cash and cash equivalents by approximately $7.2 million over the next 12 months[163].

Core Insights - Teladoc reported revenue of $629.37 million for Q1 2025, a decrease of 2.6% year-over-year, with an EPS of -$0.19, an improvement from -$0.49 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $617.67 million by 1.89%, while the EPS surpassed the consensus estimate of -$0.33 by 42.42% [1] Financial Performance Metrics - Average Revenue Per U.S. Integrated Care Member was $1.27, matching the five-analyst average estimate [4] - U.S. Integrated Care Members reached 102.5 million, exceeding the five-analyst average estimate of 101.3 million [4] - BetterHelp Paying Users totaled 0.4 million, slightly above the estimated 0.39 million [4] - Chronic Care Program Enrollment was 1.15 million, below the average estimate of 1.19 million [4] Revenue by Segment - Teladoc Health Integrated Care generated $389.47 million, surpassing the $380.91 million average estimate, reflecting a year-over-year increase of 3.3% [4] - BetterHelp reported revenues of $239.90 million, slightly above the $237.29 million estimate, but down 10.8% year-over-year [4] - BetterHelp-Other Wellness Services generated $5.46 million, below the three-analyst average estimate of $5.87 million, with a year-over-year increase of 2.9% [4] - BetterHelp-Therapy Services reported $234.44 million, exceeding the $231.85 million estimate, but down 11.1% from the previous year [4] Revenue by Type - Revenue from Other sources was $103.63 million, significantly above the two-analyst average estimate of $84.31 million, marking a year-over-year increase of 16.5% [4] - Access fees generated $525.74 million, below the $533.56 million average estimate, representing a year-over-year decline of 5.6% [4] Adjusted EBITDA - Adjusted EBITDA for BetterHelp was $7.71 million, slightly below the $7.93 million average estimate [4] - Adjusted EBITDA for Teladoc Health Integrated Care was $50.38 million, exceeding the five-analyst average estimate of $46.02 million [4]

Financial Data and Key Metrics Changes - The company reported first quarter consolidated revenue of $629.4 million, down 3% year over year, but at the high end of the guidance range [22] - Adjusted EBITDA was $58.1 million, representing a margin of 9.2%, near the high end of the guidance range [22] - Consolidated net loss per share was $0.53, compared to a net loss per share of $0.49 in the same quarter of the previous year [22][23] - Free cash flow was a net outflow of $16 million, an improvement of $11 million compared to the prior year [22] Business Line Data and Key Metrics Changes - Integrated Care segment revenue was $389.5 million, an increase of 3.3% year over year, exceeding the top end of the guidance range [24] - U.S. Integrated Care segment membership reached 102.5 million, up 12% year over year [25] - BetterHelp segment revenue was $239.9 million, down 11% year over year, but above the midpoint of the guidance range [27] - BetterHelp adjusted EBITDA was $7.7 million, down from $15.5 million in the prior year, with an adjusted EBITDA margin of 3.2% [27] Market Data and Key Metrics Changes - U.S. virtual visit volumes grew by 7%, and Chronic Care enrollment increased by 3% [13] - International revenue growth for Integrated Care was in the mid-teens on a constant currency basis [14] - BetterHelp served over 1 million unique users globally in 2024, with 40% of those being new to therapy [10] Company Strategy and Development Direction - The company announced the acquisition of Uplift, a virtual mental health company, to enhance its BetterHelp segment and support consumers seeking covered benefits [3][9] - The focus remains on expanding access to virtual mental health services and leveraging BetterHelp's marketing budget more effectively [27][75] - The company is committed to improving performance through technology investments and operational efficiencies [20][102] Management's Comments on Operating Environment and Future Outlook - The healthcare industry is facing challenges such as medical cost trends and mental health issues, which present both opportunities and challenges for the company [18][19] - The broader economic environment is being monitored closely, with signs of weakening business and consumer sentiment [20] - The company remains on track with its 2025 revenue outlook and is focused on executing strategic priorities despite macro uncertainties [21] Other Important Information - The company has a strong cash position with nearly $1.2 billion in cash and cash equivalents [41] - The acquisition of Uplift is expected to enhance the company's ability to offer insurance benefits coverage, which is anticipated to lead to higher conversion rates and user engagement [34][35] Q&A Session Summary Question: Impact of shorter duration contracts on churn and expectations - Management noted that the weekly offering has led to stronger conversion rates but also higher churn, which was expected. Overall, the net effect remains positive [48][49] Question: Evaluation of BetterHelp network's payer coverage - Management clarified that the focus was on technical capabilities and that they paused payer contracts to avoid mixed signals during the Uplift acquisition [51][52] Question: Trends in BetterHelp member growth and revenue per member - Management explained that while revenue per member has declined, this is due to onboarding a large number of new members, which will provide opportunities for upselling additional services over time [61][62] Question: Strategic focus on profitability per member - Management emphasized the importance of activating membership to drive revenue and highlighted ongoing efforts to enhance chronic care management programs [71][73] Question: BetterHelp margin improvement in the second half of the year - Management indicated that revenue growth in the second half will be driven by international efforts and insurance initiatives, with a planned pullback in ad spend [81][82] Question: Customer acquisition cost trends in BetterHelp - Management reported stable customer acquisition costs, with improved conversion rates from the weekly offering contributing to favorable trends [92][93] Question: Opportunities for cost savings in technology and G&A - Management confirmed ongoing efforts to streamline costs, with a focus on reducing technology and development spending while maintaining control over the overall cost base [100][102]

Financial Performance (Q1 2025) - Revenue for 1Q-25 was $629 million, a decrease of 3% year-over-year[4] - Net loss per share for 1Q-25 was $(0.53)[4] - Adjusted EBITDA for 1Q-25 was $58.1 million, a decrease of 8% year-over-year[4] Financial Outlook (FY2025 & Q2 2025) - The company projects FY-25 revenue to be in the range of $2,468 million to $2,576 million[5] - The company projects 2Q-25 revenue to be in the range of $614 million to $633 million[5] - The company projects FY-25 net loss per share to be in the range of $(1.40) to $(0.90)[6] - The company projects 2Q-25 net loss per share to be in the range of $(0.40) to $(0.20)[6] - The company projects FY-25 Adjusted EBITDA to be in the range of $263 million to $304 million[6] - The company projects 2Q-25 Adjusted EBITDA to be in the range of $56 million to $70 million[6] Key Operating Metrics (Q1 2025) - U S Integrated Care Members reached 102.5 million[20] - Average Revenue per Month per U S Integrated Care Member was $1.27[22]

Financial Data and Key Metrics Changes - First quarter consolidated revenue was $629.4 million, down 3% year over year, but at the high end of the guidance range [20] - Adjusted EBITDA was $58.1 million, representing a margin of 9.2% [20] - Consolidated net loss per share was $0.53, compared to a net loss per share of $0.49 in the same quarter of the previous year [20][21] - Free cash flow was a net outflow of $16 million, an improvement of $11 million compared to the prior year [22] Business Line Data and Key Metrics Changes - Integrated Care segment revenue was $389.5 million, an increase of 3.3% year over year, exceeding the top end of guidance [22] - BetterHelp segment revenue was $239.9 million, down 11% year over year, but above the midpoint of guidance [26] - U.S. Integrated Care segment membership reached 102.5 million, up 12% year over year [24] - Virtual visit volume in the U.S. increased by 7%, while Chronic Care enrollment rose by 3% [24] Market Data and Key Metrics Changes - The international business of Integrated Care showed revenue growth in the mid-teens on a constant currency basis [13][24] - BetterHelp served over 1 million unique users globally in 2024, with 40% being new to therapy [8] Company Strategy and Development Direction - The acquisition of Uplift aims to enhance the BetterHelp segment's position in virtual mental health services [6][7] - The company is focused on expanding its international markets and enhancing product offerings, including new pricing models [11] - The strategy includes leveraging BetterHelp's consumer expertise to provide more options for mental health care [7] Management's Comments on Operating Environment and Future Outlook - The healthcare industry faces challenges from medical cost trends and mental health issues, but these dynamics also present opportunities [16] - The broader economic environment is being monitored closely, with signs of weakening business and consumer sentiment [18] - The company remains on track with its 2025 revenue outlook and is optimistic about future growth potential despite macro uncertainties [19] Other Important Information - The company has a strong cash position with nearly $1.2 billion in cash and cash equivalents [38] - The acquisition of Uplift was valued at $30 million in cash, with potential additional earn-out consideration [32] Q&A Session Summary Question: Impact of shorter duration contracts on BetterHelp - Management noted that the weekly offering has led to stronger conversion rates but also higher churn, resulting in a net positive effect [41][44] Question: Evaluation of BetterHelp network's payer coverage - Management clarified that the focus was on technical capabilities and that they paused payer contracts to avoid mixed signals during the Uplift acquisition [47][49] Question: Trends in BetterHelp member growth and revenue per member - Management explained that while revenue per member has declined, the significant increase in membership provides opportunities for upselling additional services [56][58] Question: BetterHelp margin improvement expectations - Management indicated that the second half of the year would see revenue growth driven by international efforts and insurance initiatives, with a planned pullback in ad spend [75][77] Question: Customer acquisition cost trends - Management reported stable customer acquisition costs, with favorable trends due to improved conversion rates from the weekly offering [85][86] Question: Cost-saving opportunities in technology and G&A - Management emphasized ongoing efforts to streamline costs, with a focus on technology and development spending being down year over year [92][95]